These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 25070952)

  • 21. Small Heterodimer Partner and Fibroblast Growth Factor 19 Inhibit Expression of NPC1L1 in Mouse Intestine and Cholesterol Absorption.
    Kim YC; Byun S; Seok S; Guo G; Xu HE; Kemper B; Kemper JK
    Gastroenterology; 2019 Mar; 156(4):1052-1065. PubMed ID: 30521806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nuclear receptors and cholesterol metabolism in the intestine.
    Moschetta A
    Atheroscler Suppl; 2015 Feb; 17():9-11. PubMed ID: 25659870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intestinal specific LXR activation stimulates reverse cholesterol transport and protects from atherosclerosis.
    Lo Sasso G; Murzilli S; Salvatore L; D'Errico I; Petruzzelli M; Conca P; Jiang ZY; Calabresi L; Parini P; Moschetta A
    Cell Metab; 2010 Aug; 12(2):187-93. PubMed ID: 20674863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and ApoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1.
    Singaraja RR; Bocher V; James ER; Clee SM; Zhang LH; Leavitt BR; Tan B; Brooks-Wilson A; Kwok A; Bissada N; Yang YZ; Liu G; Tafuri SR; Fievet C; Wellington CL; Staels B; Hayden MR
    J Biol Chem; 2001 Sep; 276(36):33969-79. PubMed ID: 11423537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholesterol and Lipoprotein Metabolism and Atherosclerosis: Recent Advances In reverse Cholesterol Transport.
    Wang HH; Garruti G; Liu M; Portincasa P; Wang DQ
    Ann Hepatol; 2017 Nov; 16(Suppl. 1: s3-105.):s27-s42. PubMed ID: 29080338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-144 regulates hepatic ATP binding cassette transporter A1 and plasma high-density lipoprotein after activation of the nuclear receptor farnesoid X receptor.
    de Aguiar Vallim TQ; Tarling EJ; Kim T; Civelek M; Baldán Á; Esau C; Edwards PA
    Circ Res; 2013 Jun; 112(12):1602-12. PubMed ID: 23519696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The lipid metabolism of the small intestine and its correlation to the lipid and lipoprotein metabolism of the total organism].
    Gangl A
    Acta Med Austriaca Suppl; 1975; 2():1-49. PubMed ID: 1065179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of scavenger receptors SR-BI and CD36 in selective sterol uptake in the small intestine.
    Werder M; Han CH; Wehrli E; Bimmler D; Schulthess G; Hauser H
    Biochemistry; 2001 Sep; 40(38):11643-50. PubMed ID: 11560515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biliary and nonbiliary contributions to reverse cholesterol transport.
    Temel RE; Brown JM
    Curr Opin Lipidol; 2012 Apr; 23(2):85-90. PubMed ID: 22262055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Niemann-Pick C1 Like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis.
    Davis HR; Zhu LJ; Hoos LM; Tetzloff G; Maguire M; Liu J; Yao X; Iyer SP; Lam MH; Lund EG; Detmers PA; Graziano MP; Altmann SW
    J Biol Chem; 2004 Aug; 279(32):33586-92. PubMed ID: 15173162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo evidence for a role of adipose tissue SR-BI in the nutritional and hormonal regulation of adiposity and cholesterol homeostasis.
    Yvan-Charvet L; Bobard A; Bossard P; Massiéra F; Rousset X; Ailhaud G; Teboul M; Ferré P; Dagher G; Quignard-Boulangé A
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1340-5. PubMed ID: 17363694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ABCA1 and nascent HDL biogenesis.
    Wang S; Smith JD
    Biofactors; 2014; 40(6):547-54. PubMed ID: 25359426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver X receptor agonist modulation of cholesterol efflux in mice with intestine-specific deletion of microsomal triglyceride transfer protein.
    Xie Y; Kennedy S; Sidhu R; Luo J; Ory DS; Davidson NO
    Arterioscler Thromb Vasc Biol; 2012 Jul; 32(7):1624-31. PubMed ID: 22580900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholesteryl ester transfer protein (CETP) inhibition beyond raising high-density lipoprotein cholesterol levels: pathways by which modulation of CETP activity may alter atherogenesis.
    Klerkx AH; El Harchaoui K; van der Steeg WA; Boekholdt SM; Stroes ES; Kastelein JJ; Kuivenhoven JA
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):706-15. PubMed ID: 16439711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In Vitro Human Cell-Based Experimental Models for the Evaluation of Enteric Metabolism and Drug Interaction Potential of Drugs and Natural Products.
    Li AP
    Drug Metab Dispos; 2020 Oct; 48(10):980-992. PubMed ID: 32636209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Scavenger receptor class B type I is a plasma membrane cholesterol sensor.
    Saddar S; Carriere V; Lee WR; Tanigaki K; Yuhanna IS; Parathath S; Morel E; Warrier M; Sawyer JK; Gerard RD; Temel RE; Brown JM; Connelly M; Mineo C; Shaul PW
    Circ Res; 2013 Jan; 112(1):140-51. PubMed ID: 23023567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intestinal Farnesoid X Receptor Controls Transintestinal Cholesterol Excretion in Mice.
    de Boer JF; Schonewille M; Boesjes M; Wolters H; Bloks VW; Bos T; van Dijk TH; Jurdzinski A; Boverhof R; Wolters JC; Kuivenhoven JA; van Deursen JM; Oude Elferink RPJ; Moschetta A; Kremoser C; Verkade HJ; Kuipers F; Groen AK
    Gastroenterology; 2017 Apr; 152(5):1126-1138.e6. PubMed ID: 28065787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver X receptors: Xcreting Xol to combat atherosclerosis.
    Francis GA; Annicotte JS; Auwerx J
    Trends Mol Med; 2002 Oct; 8(10):455-8. PubMed ID: 12383763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Down-regulation of intestinal scavenger receptor class B, type I (SR-BI) expression in rodents under conditions of deficient bile delivery to the intestine.
    Voshol PJ; Schwarz M; Rigotti A; Krieger M; Groen AK; Kuipers F
    Biochem J; 2001 Jun; 356(Pt 2):317-25. PubMed ID: 11368757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FXR an emerging therapeutic target for the treatment of atherosclerosis.
    Mencarelli A; Fiorucci S
    J Cell Mol Med; 2010 Jan; 14(1-2):79-92. PubMed ID: 20041971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.